1. Home
  2. TNC vs DMRA Comparison

TNC vs DMRA Comparison

Compare TNC & DMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$86.70

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

DMRA

Damora Therapeutics Inc. Common Stock

N/A

Current Price

$33.42

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TNC
DMRA
Founded
1870
2011
Country
United States
United States
Employees
N/A
7
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
TNC
DMRA
Price
$86.70
$33.42
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$79.00
$43.00
AVG Volume (30 Days)
154.0K
864.6K
Earning Date
05-04-2026
05-11-2026
Dividend Yield
1.53%
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$1,137,600,000.00
N/A
Revenue This Year
$5.77
N/A
Revenue Next Year
$4.95
N/A
P/E Ratio
$8,579.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$60.18
$16.50
52 Week High
$91.93
$34.89

Technical Indicators

Market Signals
Indicator
TNC
DMRA
Relative Strength Index (RSI) 50.15 67.41
Support Level $83.41 $22.71
Resistance Level $87.65 N/A
Average True Range (ATR) 2.47 2.81
MACD -0.19 0.44
Stochastic Oscillator 52.99 84.06

Price Performance

Historical Comparison
TNC
DMRA

About TNC Tennant Company

Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.

About DMRA Damora Therapeutics Inc. Common Stock

Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.

Share on Social Networks: